do all glp-1 cause pancreatitis Why Does Pancreatitis? Risk Factors Explained GLP-1 Genetics: How Genes Affect

Recently published studies of islet cell function reveal unexpected features of glucagon-like peptide-1 (GLP-1) receptor-mediated signal transduction...

Explore the intersection of GLP-1 therapies and gut health to manage metabolic dysfunction and support patient wellness.

June 8 (Reuters) - Use of GLP-1 drugs for diabetes or obesity early in the first trimester of pregnancy, before a woman realizes she is pregnant, is not a cause for alarm, a large new data analysis suggests

Should GLP-1 therapy extend to normal-weight patients with cardiometabolic risk

En gerekli olan ey de zellikle gen teknolojileriyle ok daha salkl, kiiye zel zmler bulunmas

Obesity medicine physician Jessica Duncan discusses the article "GLP-1 weight regain: Why stopping medication leads to weight return." Jessica explains that expecting to maintain weight loss after abruptly stopping GLP-1 therapy is unrealistic because it ignores the physiological forces that defend a person's prior weight